Statistically Driven Metabolite and Lipid Profiling of Patients from the Undiagnosed Diseases Network.

ABSTRACT: Advancements in molecular separations coupled with mass spectrometry have enabled metabolome analyses for clinical cohorts. A population of interest for metabolome profiling is patients with rare disease for which abnormal metabolic signatures may yield clues into the genetic basis, as well as mechanistic drivers of the disease and possible treatment options. We undertook the metabolome profiling of a large cohort of patients with mysterious conditions characterized through the Undiagnosed Diseases Network (UDN). Due to the size and enrollment procedures, collection of the metabolomes for UDN patients took place over 2 years. We describe the study designed to adjust for measurements collected over a long time scale and how this enabled statistical analyses to summarize the metabolome of in

SUBMITTER: Webb-Robertson BM 

PROVIDER: S-EPMC7183858 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature